Your browser doesn't support javascript.
loading
hsa_circ_0092339 acts as a molecular sponge in castration-resistant prostate cancer via the hsa-mir-940/C-MYC axis.
Li, Hanlin; Yang, Yanjie; Yu, Jianpeng; Zhang, Boya; Chen, Xuanrong; Zhu, Shimiao; Niu, Yuanjie; Shang, Zhiqun.
Afiliação
  • Li H; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Yang Y; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Yu J; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Zhang B; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Chen X; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Zhu S; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Niu Y; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
  • Shang Z; Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
Epigenomics ; 2022 Jul 19.
Article em En | MEDLINE | ID: mdl-35852112
Our research breaks the mold by investigating a novel function of RNA and a novel regulatory mechanism. Our research provides a new therapeutic target for prostate cancer treatment and broadens the understanding of prostate cancer.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article